The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice, but not diabetes outcome in female non-obese diabetic (NOD) mice

References

• Neumann D, Schneider EH, Seifert R. Analysis of histamine receptor knockout mice in models of inflammation. J Pharmacol Exp Ther. 2014;348:2–11.
   PubMed Web of Science ®Google Scholar
• Rajasekaran N, Solomon S, Watanabe T, Ohtsu H, Gajda M, Bräuer R, et al. Histidine decarboxylase but not histamine receptor 1 or 2 deficiency protects from K/BxN serum-induced arthritis. Int Immunol. 2009;21:1263–8.
   PubMed Web of Science ®Google Scholar
• Bene L, Sápi Z, Bajtai A, Buzás E, Szentmihályi A, Arató A, et al. Partial protection against dextran sodium sulphate induced colitis in histamine-deficient, histidine decarboxylase knockout mice. J Pediatr Gastroenterol Nutr. 2004;39:171–6.
   PubMed Web of Science ®Google Scholar
• Rozenberg I, Sluka SH, Rohrer L, Hofmann J, Becher B, Akhmedov A, et al. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arterioscler Thromb Vasc Biol. 2010;30:923–30.
   PubMed Web of Science ®Google Scholar
• Wang KY, Tanimoto A, Yamada S, Guo X, Ding Y, Watanabe T, et al. Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice. Am J Pathol. 2010;177:713–23.
   PubMed Web of Science ®Google Scholar
• Noubade R, Milligan G, Zachary JF, Blankenhorn EP, del Rio R, Rincon M, et al. Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. J Clin Invest. 2007;117:3507–18.
   PubMed Web of Science ®Google Scholar
• Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature. 2001;413:420–5.
   PubMed Web of Science ®Google Scholar
• Vanbervliet B, Akdis M, Vocanson M, Rozières A, Benetière J, Rouzaire P, et al. Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-γ/IL-17 balance in T cell-mediated skin inflammation. J Allergy Clin Immunol. 2011;127:943–53.
   PubMed Web of Science ®Google Scholar
• Ma RZ, Gao J, Meeker ND, Fillmore PD, Tung KS, Watanabe T, et al. Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science. 2002;297:620–3.
   PubMed Web of Science ®Google Scholar
• Saligrama N, Noubade R, Case LK, Poynter ME, Teuscher C. H1R expression by CD11B+ cells is not required for susceptibility to experimental allergic encephalomyelitis. Cell Immunol. 2012;278:27–34.
   PubMed Web of Science ®Google Scholar
• Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell. 1996;8:291–7.
   Google Scholar
• Cnop M, Welsh N, Jonas J, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005;54S2:S97–107.
   Web of Science ®Google Scholar
• Campoli-Richards DM, Buckley MM, Fitton A. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs. 1990;40:762–81.
   PubMed Web of Science ®Google Scholar
• Anvari E, Fred RG, Welsh N. The H1-receptor antagonist cetirizine protects partially against cytokine- and hydrogen peroxide-induced β-TC6 cell death in vitro. Pancreas. 2014;43:624–9.
   PubMed Web of Science ®Google Scholar
• Yoneda K, Yamamoto T, Ueta E, Osaki T. Suppression by azelastine hydrochloride of NF-kappa B activation involved in generation of cytokines and nitric oxide. Jpn J Pharmacol. 1997;73:145–53.
   PubMedGoogle Scholar
• Roumestan C, Henriquet C, Gougat C, Michel A, Bichon F, Portet K, et al. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and –independent mechanisms. Clin Exp Allergy. 2008;38:947–56.
   PubMed Web of Science ®Google Scholar
• Arnold R, Rihoux J, König W. Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549). Clin Exp Allergy. 1999;29:1681–91.
   PubMed Web of Science ®Google Scholar
• Jinquan T, Reimert CM, Deleuran B, Zachariae C, Simonsen C, Thestrup-Pedersen K. Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes. J Allergy Clin Immunol. 1995;95:979–86.
   PubMed Web of Science ®Google Scholar
• Ashenager MS, Grgela T, Aragane Y, Kawada A. Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines. J Investig Allergol Clin Immunol. 2007;17:20–6.
   PubMed Web of Science ®Google Scholar
• Roch-Arveiller M, Tissot M, Idohou N, Sarfati G, Giroud JP, Raichvarg D. In vitro effect of cetirizine on PGE2 release by rat peritoneal macrophages and human monocytes. Agents Actions. 1994;43:13–16.
   PubMedGoogle Scholar
• Cheria-Sammari S, Aloui R, Gormand F, Chabannes B, Gallet H, Grosclaude M, et al. Leukotriene B4 production by blood neutrophils in allergic rhinitis--effects of cetirizine. Clin Exp Allergy. 1995;25:729–36.
   PubMed Web of Science ®Google Scholar
• Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol. 1989;83:905–12.
   PubMed Web of Science ®Google Scholar
• Dridi D, Ben Attia M, Reinberg A, Boughattas NA. [Circadian rhythms in the toxic effects of the histamine antagonist cetirizine in mice]. Pathol Biol (Paris). 2005;53:193–8; French.
   PubMed Web of Science ®Google Scholar
• Patel AC, Nunez NP, Perkins SN, Barrett JC, Hursting SD. Effects of energy balance on cancer in genetically altered mice. J Nutr. 2004;134:3394S–8S.
   PubMed Web of Science ®Google Scholar
• Bach JF, Mathis D. The NOD mouse. Res Immunol. 1997;148:285–6.
   PubMedGoogle Scholar
• Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5:219–26.
   PubMed Web of Science ®Google Scholar
• La Torre D, Lernmark A. Immunology of beta-cell destruction. Adv Exp Med Biol. 2010;654:537–83.
   PubMed Web of Science ®Google Scholar
• Wahlberg J, Vaarala O, Ludvigsson J; ABIS Study Group. Asthma and allergic symptoms and type 1 diabetes-related autoantibodies in 2.5-yr-old children. Pediatr Diabetes. 2011;12:604–10.
   PubMed Web of Science ®Google Scholar
• Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T. Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes. 2001;50:385–91.
   PubMed Web of Science ®Google Scholar
• Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T. Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice. Diabetes. 2001;50:376–84.
   PubMed Web of Science ®Google Scholar
• McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity. 2014;41:36–48.
   PubMed Web of Science ®Google Scholar
• Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141–50.
   PubMed Web of Science ®Google Scholar
• Spencer M, Finlin BS, Unal R, Zhu B, Morris AJ, Shipp LR, et al. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes. 2013;62:1709–17.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, et al. Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 2012;126:2739–48.
   PubMed Web of Science ®Google Scholar